$FRSH

Taylor Jennifer H sold $69K of FRSH

Taylor Jennifer H sold 6,618 shares of Freshworks Inc. (FRSH) at $10.44 on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Taylor Jennifer H
Published Jul 2, 2026, 9:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FRSH
Neutral
high confidence
Mentioned
$FRSH
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRSHNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (shares, price, total value) executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there’s no accompanying fundamental catalyst in the text.

03

What to watch

The filing doesn’t reveal the director’s broader intent beyond the plan; without context on total holdings, frequency of sales, or concurrent company news, signal strength is limited.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-02 (after-hours/late day) for a same-day sale dated 2026-07-02.

Background

The article is an SEC Form 4 insider transaction disclosure for Freshworks Inc. (FRSH).

Company-level read

Ticker impact

$FRSHNeutralHigh confidence
Context

Freshworks director Taylor Jennifer H sold 6,618 shares on 2026-07-02 under a 10b5-1 plan, worth about $69.1K.

Expected impact

Low likelihood of a sustained price move; any near-term impact would be sentiment-only and typically fades.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicitly stated pre-arranged 10b5-1 plan, and the disclosed value ($69K) is small relative to typical market capitalization-driven moves.

Market effects

Minimal—single-company insider sale with no operational/regulatory catalyst disclosed.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with periods of reduced confidence; traders may still watch for follow-on sales or other disclosures.

Key entities

  • Freshworks Inc.

    Issuer of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.

  • Taylor Jennifer H

    Director who sold 6,618 shares on 2026-07-02; holdings after transaction: 62,673 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRSHMed

Why Are Freshworks (FRSH) Shares Soaring Today

Freshworks (FRSH) shares rose 5.4% in pre-market trading after S&P Dow Jones Indices announced its addition to the S&P SmallCap 600, effective October 8, 2026. The company will replace BioLife Solutions, which is being acquired by Repligen. Freshworks is up 20.6% year-to-date, reaching a 52-week high of $13.99. However, long-term investors have seen a decline in value over five years.

$ZSHigh

Premarket movers: Constellation, Zscaler rise while Nike falls

U.S. stock futures rose on Tuesday, with Nasdaq Composite hitting a record high. Zscaler shares gained 2.2% after reaffirming fiscal 2027 revenue and earnings guidance. Nike shares fell 1% after a downgrade to Sell and a price target cut to $27.50. Vaxcyte stock dropped 3.7% following a $1 billion capital raise. Constellation Energy stock climbed 3% after a deal with Amazon and potential agreement with Google. Freshworks stock rose 3.9% after being added to the S&P SmallCap 600 index.

$FRSHHigh

Why is Freshworks stock climbing today?

Freshworks Inc. (FRSH) stock rose 3.9% in pre-market trading after being added to the S&P SmallCap 600 index, replacing BioLife Solutions. The move is driven by passive fund buying ahead of the October 8 rebalancing. Analysts have a consensus Buy rating with a $14.79 average price target. The broader market's positive tone and AI-driven software demand also support the stock's rally.

$FRSHHighAI 8/10

Freshworks to Replace BioLife Solutions in S&P SmallCap 600

S&P Dow Jones Indices announced Freshworks (FRSH) will replace BioLife Solutions (BLFS) in the S&P SmallCap 600 on October 8, 2026. Repligen (RGN) is acquiring BioLife for $1.5B, with BioLife shareholders receiving $11.25 per share in cash and 0.1442 shares of Repligen stock. Freshworks reported Q2 2026 revenue of $237.4M, up 16% YoY, and its first GAAP profitability in 2026.

$FRSHHighAI 8/10

Why is Freshworks stock rallying today?

Freshworks Inc. (FRSH) stock rose 4.4% in after-hours trading on Monday after being added to the S&P SmallCap 600 index, effective October 8. The stock traded at $13.80, near its 52-week high of $13.99. Analysts have a 'Moderate Buy' rating and an average price target of $14.46. The move was driven by index inclusion, not broader market trends.